Cargando…
KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution
SIMPLE SUMMARY: Cancer therapies directly targeting the mitogen-activated protein kinase (MAPK) pathway lead to cancer drug resistance. Resistance has been linked to compensatory RAS overexpression, but the mechanisms underlying this overexpression remain unclear. Here, we find that MEK inhibitors (...
Autores principales: | Vidal-Cruchez, Olivia, Nicolini, Victoria J., Rete, Tifenn, Jacquet, Karine, Rezzonico, Roger, Lacoux, Caroline, Domdom, Marie-Angela, Roméo, Barnabé, Roux, Jérémie, Hubstenberger, Arnaud, Mari, Bernard, Mograbi, Baharia, Hofman, Paul, Brest, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296394/ https://www.ncbi.nlm.nih.gov/pubmed/37370689 http://dx.doi.org/10.3390/cancers15123078 |
Ejemplares similares
-
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022) -
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
por: Giuliano, Sandy, et al.
Publicado: (2023) -
More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021) -
Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021) -
COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)